Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy

Immunological Investigations

Volumn 40, Issue 4, 2011, Pages 367-382

  Park, Min Ju ^a   Bae, Jae Ho ^a   Chung, Joo Seop ^a,b   Kim, Sun Hee ^a,b   Kang, Chi Dug ^a,b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Hematoporphyrin; NK cells; NKG2D ligands; Photodynamic therapy

Indexed keywords

HEMATOPORPHYRIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 CHAIN RELATED A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 CHAIN RELATED B; MESSENGER RNA; MONOCLONAL ANTIBODY; NATURAL KILLER CELL RECEPTOR NKG2D LIGAND; NKG2D MONOCLONAL ANTIBODY; PROTEIN; UL16 BINDING PROTEIN 1; UL16 BINDING PROTEIN 2; UL16 BINDING PROTEIN 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LUNG CANCER; NATURAL KILLER CELL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RNA TRANSCRIPTION; STOMACH TUMOR; TUMOR CELL; UPREGULATION;

ADENOCARCINOMA; CARCINOMA; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOPORPHYRINS; HUMANS; KILLER CELLS, NATURAL; LIGANDS; LUNG NEOPLASMS; NEOPLASMS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PHOTOCHEMOTHERAPY; STOMACH NEOPLASMS; UP-REGULATION;

EID: 79953798836     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2010.551435     Document Type: Article

References (51)

1. Armeanu, S., Bitzer, M., Lauer, U. M., Venturelli, S., Pathil, A., Krusch, M., Kaiser, S., Jobst, J., Smirnow, I., Wagner, A., and others (2005). Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Res. 65:6321-6329. (Pubitemid 40994418)
2. Bae, J. H., Kim, J. Y., Kim, M. J., Chang, S. H., Park, Y. S., Son, C. H., Park, S. J., Chung, J. S., Lee, E. Y., Kim, S. H., and others (2010). Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70. J. Immunother. 33:391-401.
3. Barr, H., Tralau, C. J., Boulos, P. B., MacRobert, A. J., Tilly, R., Bown, S. G. (1987). The contrastingmechanisms of colonic collagen damage between photodynamic therapy and thermal injury. Photochem. Photobiol. 46:795-800.
4. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., Spies, T (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727-729.
5. Biassoni, R., Cantoni, C.,Marras, D., Giron-Michel, J., Falco,M., Moretta, L., Dimasi, N. (2003). Human natural killer cell receptors: Insights into their molecular function and structure. J. Cell. Mol. Med. 7:376-387. (Pubitemid 44151688)
6. Biron, C. A. (1997) Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9:24-34. (Pubitemid 27098860)
7. Borchers, M. T., Harris, N. L., Wesselkamper, S. C., Vitucci, M., Cosman, D. (2006). NKG2D ligands are expressed on stressed human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 291:L222-L231. (Pubitemid 44148106)
8. Buytaert, E., Dewaele,M., Agostinis, P. (2007).Molecular effectors ofmultiple cell death pathways initiated by photodynamic therapy. Biochim. Biophys, Acta 1776:86-107. (Pubitemid 47332075)
9. Castano, A. P.,Mroz, P., Hamblin,M. R. (2006). Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer 6:535-545.
10. Cecic, I., Korbelik, M. (2002). Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett. 183:43-51. (Pubitemid 34607350)
11. Cecic, I., Parkins, C. S., Korbelik, M. (2001). Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors. Photochem. Photobiol. 74:712-720.
12. Cecic, I., Stott, B., Korbelik, M. (2006). Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy. Int. Immunopharmacol. 6:1259-1266. (Pubitemid 43884994)
13. Cerwenka, A., Bakker, A. B., McClanahan, T.,Wagner, J.,Wu, J., Phillips, J. H., Lanier, L. L. (2000). Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12:721-727.
14. Cooper, M. A., Fehniger, T. A., Caligiuri, M. A. (2001). The biology of human natural killer-cell subsets. Trends Immunol. 22:633-640. (Pubitemid 33043908)
15. de Vree, W. J., Essers, M. C., Koster, J. F., Sluiter, W. (1997). Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. Cancer Res. 57:2555-2558. (Pubitemid 27283755)
16. Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., Raulet, D. H. (2000). Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:119-126.
17. Dougherty, T. J., Gomer, C. J., Henderson, B.W., Jori, G., Kessel, D., Korbelik, M.,Moan, J., Peng, Q. (1998). Photodynamic therapy. J. Natl. Cancer Inst. 90:889-905. (Pubitemid 28304157)
18. Eagle, R. A., Traherne, J. A., Ashiru, O., Wills, M. R., Trowsdale, J. (2006). Regulation of NKG2D ligand gene expression. Hum. Immunol. 67:159-169. (Pubitemid 43673921)
19. Gasser, S., Orsulic, S., Brown, E. J., Raulet, D. H. (2005). The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436:1186-1190. (Pubitemid 41232299)
20. Gollnick, S. O., Evans, S. S., Baumann, H., Owczarczak, B., Maier, P., Vaughan, L., Wang,W. C., Unger, E., Henderson, B.W. (2003). Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br. J. Cancer 88:1772-1779. (Pubitemid 36760423)
21. Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., Spies, T. (2001). Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2:255-260. (Pubitemid 33706003)
22. Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., Spies, T. (1999). Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA 96:6879-6884. (Pubitemid 29274978)
23. + T cells and dependent on natural killer cells. Br. J. Cancer 96:1839-1848. (Pubitemid 46912014)
24. Kato, N., Tanaka, J., Sugita, J., Toubai, T., Miura, Y., Ibata, M., Syono, Y., Ota, S., Kondo, T., Asaka, M., and others (2007) Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells. Leukemia 21:2103-2108. (Pubitemid 47423800)
25. Kim, J. Y., Bae, J. H., Lee, S. H., Lee, E. Y., Chung, B. S., Kim, S. H., Kang, C. D. (2008). Induction of NKG2D ligands and subsequent enhancement of NK Cell-mediated lysis of cancer cells by arsenic trioxide. J. Immunother. 31:475-486.
26. Kim, J. Y., Son, Y. O., Park, S. W., Bae, J. H., Chung, J. S., Kim, H. H., Chung, B. S., Kim, S. H., Kang, C. D. (2006). Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation. Exp. Mol. Med. 38:474-484.
27. Korbelik, M., Sun, J. (2001). Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line. Int. J. Cancer 93:269-274. (Pubitemid 32574284)
28. Kubba, A. K. (1999). Role of photodynamic therapy in the management of gastrointestinal cancer. Digestion 60:1-10. (Pubitemid 29042085)
29. Lanier, L. L. (2001). On guard-activating NK cell receptors. Nat. Immunol. 2:23-27.
30. Lee, S. J., Son, Y. O., Kim, H., Kim, J. Y., Park, S. W., Bae, J. H., Kim, H. H., Lee, E. Y., Chung, B. S., Kim, S. H., and others (2007). Suppressive effect of a standardized mistletoe extract on the expression of activatory NK receptors and function of human NK cells. J. Clin. Immunol. 27:477-485. (Pubitemid 47319251)
31. Ljunggren, H. G., Karre, K. (1990). In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11:237-244.
32. Ljunggren, H. G., Malmberg, K. J. (2007). Prospects for the use of NK cells in immunotherapy of human cancer. Nat. Rev. Immunol. 7:329-339.
33. Maki, G., Klingemann, H. G., Martinson, J. A., Tam, Y. K. (2001). Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92. J. Hematother. Stem Cell Res. 10:369-383. (Pubitemid 32673241)
34. McBride, G. (2002). Studies expand potential uses of photodynamic therapy. J. Natl. Cancer Instit. 94:1740-1742. (Pubitemid 36004348)
35. McCaughan, J. S., Jr., Guy, J. T., Hawley, P., Hicks,W., Inglis,W., Laufman, L., May, E,. Nims, T. A., Sherman, R. (1983). Hematoporphyrin- derivative and photoradiation therapy of malignant tumors. Lasers Surg. Med. 3:199-209. (Pubitemid 14163736)
36. McCaughan, J. S., Jr., Hicks, W., Laufman, L., May, E., Roach, R. (1984). Palliation of esophageal malignancy with photoradiation therapy. Cancer 54:2905-2910. (Pubitemid 15184069)
37. Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., Moretta, L. (2001). Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197-223. (Pubitemid 32368034)
38. Nseyo, U. O., Whalen, R. K., Duncan, M. R., Berman, B., Lundahl, S. L. (1990). Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report. Urology 36:167-171. (Pubitemid 20239031)
39. Ortel, B., Shea, C. R., Calzavara-Pinton, P. (2009). Molecular mechanisms of photodynamic therapy. Front. Biosci. 14:4157-4172.
40. Park, S. W., Bae, J. H., Kim, S. D., Son, Y. O., Kim, J. Y., Park, H. J., Lee, C. H., Park, D. Y., Lee, M. K., Chung, B. S., and others (2007). Comparison of level of NKG2D ligands between normal and tumor tissue using multiplex RT-PCR. Cancer Invest. 25:299-307.
41. Poggi, A., Venturino, C., Catellani, S., Clavio, M., Miglino, M., Gobbi, M., Steinle, A., Ghia, P, Stella S, Caligaris-Cappio F and others (2004) Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid. Cancer Res. 64:9172-9179. (Pubitemid 39665533)
42. Rohner, A., Langenkamp, U., Siegler, U., Kalberer, C. P., Wodnar-Filipowicz, A. (2007) .Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis. Leuk. Res. 31:1393-1402. (Pubitemid 47212430)
43. Sharman, W. M., Allen, C. M., van Lier, J. E. (2000). Role of activated oxygen species in photodynamic therapy. Meth. Enzymol. 319:376-400. (Pubitemid 30448059)
44. Skov, S., Pedersen, M. T., Andresen, L., Straten, P. T., Woetmann, A., Odum, N. (2005). Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. Cancer Res. 65:11136-11145. (Pubitemid 41713385)
45. Tam, Y. K., Martinson, J. A., Doligosa, K., Klingemann, H. G. (2003). Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy. Cytotherapy 5:259-272. (Pubitemid 37086771)
46. Trinchieri, G. (1989). Biology of natural killer cells. Adv. Immunol. 47:187-376. (Pubitemid 20010960)
47. van Duijnhoven, F. H., Aalbers, R. I., Rovers, J. P., Terpstra, O. T., Kuppen, P. J. (2003). Immunological aspects of photodynamic therapy of liver tumors in a rat model for colorectal cancer. Photochem. Photobiol. 78:235-240.
48. Vivier, E., Tomasello, E., Paul, P. (2002). Lymphocyte activation via NKG2D: Towards a new paradigm in immune recognition? Curr. Opin. Immunol. 14:306-311. (Pubitemid 34327971)
49. Yom, S. S., Busch, T. M., Friedberg, J. S., Wileyto, E. P., Smith, D., Glatstein, E., Hahn, S. M. (2003). Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy. Photochem. Photobiol. 78:75-81.
50. Zhang, C., Wang, Y., Zhou, Z., Zhang, J., Tian, Z. (2009). Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis. Cancer Immunol. Immunother. 58:1275-1285.
51. Ziolkowski, P., Symonowicz, K., Milach, J., Zawirska, B., Szkudlarek, T. (1997). In vivo tumor necrosis factor-alpha induction following chlorin e6-photodynamic therapy in Buffalo rats. Neoplasma 44:192-196. (Pubitemid 27322502)